Case pg334-5, fig17, VTA71, table2. Soma notes not specified.. Terminal notes TB & bizbenzimide injs, see fig6H.

Case pg326, fig7, VTA61, table2. Soma notes not specified.. Terminal notes TB & bisbenzimide injs centred in different parts of ACB & dorsally adjacent parts of the striatum (see fig 6, VTA61).

Case pg330-333, fig13, VTA129, table2. Soma notes not specified.. Terminal notes TB & bizbenzimide injs, see fig6F, spread into PIR & other parts of cortex none of which receive input from VTA.

Case pg329, fig10, VTA92, table2. Soma notes not specified.. Terminal notes TB inj into supragenual field (Lindvall et al 78, BR142:1), see fig6C.

Case pg328-9, fig9, VTA70, table2. Soma notes not specified.. Terminal notes TB & bisbenzimide injs, only injections into medial 1/2 of nucleus labelled VTA region, (eg see fig6B).

Case pg334-5, fig17, VTA71, table2. Soma notes not specified.. Terminal notes TB & bizbenzimide injs, see fig6H.

Case pg326, fig7, VTA61, table2. Soma notes not specified.. Terminal notes TB & bisbenzimide injs centred in different parts of ACB & dorsally adjacent parts of the striatum (see fig 6, VTA61).

Case pg333, fig14. Soma notes not specified.. Terminal notes TB injections into CA1/CA3/DG, spread into ISO but control injections ruled out involvement in connections.

Case pg334-5, fig17, VTA71, table2. Soma notes not specified.. Terminal notes TB & bizbenzimide injs, see fig6H.

Case pg336-338, fig18, VTA67, table2. Soma notes could be axons of passage. Terminal notes TB & bizbenzimide injs, see fig6I.

Case pg330, fig12, VTA90, table2. Soma notes not specified.. Terminal notes TB or bisbenzimide injs, see fig6E.

Case pg326, fig7, VTA61, table2. Soma notes not specified.. Terminal notes TB & bisbenzimide injs centred in different parts of ACB & dorsally adjacent parts of the striatum (see fig 6, VTA61).

Case pg333, fig14. Soma notes not specified.. Terminal notes TB injections into CA1/CA3/DG, spread into ISO but control injections ruled out involvement in connections.

Case pg330-333, fig13, VTA129, table2. Soma notes not specified.. Terminal notes TB & bizbenzimide injs, see fig6F, spread into PIR & other parts of cortex none of which receive input from VTA.

Case pg329, fig10, VTA92, table2. Soma notes not specified.. Terminal notes TB inj into supragenual field (Lindvall et al 78, BR142:1), see fig6C.

Case pg329-30, fig11, VTA91, table2. Soma notes a least partially topographically organized, neurons only found in ventral part. Terminal notes TB or bisbenzimide injs into pregenual field (Lindvall et al 78, BR142:1), see fig6D.

Case pg328-9, fig9, VTA70, table2. Soma notes not specified.. Terminal notes TB & bisbenzimide injs, only injections into medial 1/2 of nucleus labelled VTA region, (eg see fig6B).

Case pg333-4, fig15, VTA73, table2. Soma notes medial 1/3. Terminal notes TB & bizbenzimide injs, see fig6G.

Case pg334-5, fig17, VTA71, table2. Soma notes massive labelling. Terminal notes TB & bizbenzimide injs into (LC/PCG/MEV/CB), see fig6H.

Case pg330, fig12, VTA90, table2. Soma notes not specified.. Terminal notes TB or bisbenzimide injs, see fig6E.

Case pg326, fig7, VTA61, table2. Soma notes not specified.. Terminal notes TB & bisbenzimide injs centred in different parts of ACB & dorsally adjacent parts of the striatum (see fig 6, VTA61).

Case pg330-333, fig13, VTA129, table2. Soma notes not specified.. Terminal notes TB & bizbenzimide injs, see fig6F, spread into PIR & other parts of cortex none of which receive input from VTA.

Case pg329, fig10, VTA92, table2. Soma notes not specified.. Terminal notes TB inj into supragenual field (Lindvall et al 78, BR142:1), see fig6C.

Case pg328-9, fig9, VTA70, table2. Soma notes not specified.. Terminal notes TB & bisbenzimide injs, only injections into medial 1/2 of nucleus labelled VTA region, (eg see fig6B).

Case pg333-4, fig15, VTA73, table2. Soma notes not specified.. Terminal notes TB & bizbenzimide injs, see fig6G.

Case pg330, fig12, VTA90, table2. Soma notes not specified.. Terminal notes TB or bisbenzimide injs, see fig6E.

Case pg326, fig7, VTA61, table2. Soma notes not specified.. Terminal notes TB & bisbenzimide injs centred in different parts of ACB & dorsally adjacent parts of the striatum (see fig 6, VTA61).

Case pg330-333, fig13, VTA129, table2. Soma notes not specified.. Terminal notes TB & bizbenzimide injs, see fig6F, spread into PIR & other parts of cortex none of which receive input from VTA.

Case pg329, fig10, VTA92, table2. Soma notes not specified.. Terminal notes TB inj into supragenual field (Lindvall et al 78, BR142:1), see fig6C.

Case pg329-30, fig11, VTA91, table2. Soma notes not specified.. Terminal notes TB or bisbenzimide injs into pregenual field (Lindvall et al 78, BR142:1), see fig6D.

Case pg328-9, fig9, VTA70, table2. Soma notes not specified.. Terminal notes TB & bisbenzimide injs, only injections into medial 1/2 of nucleus labelled VTA region, (eg see fig6B).

Case pg333-4, fig15, VTA73, table2. Soma notes not specified.. Terminal notes TB & bizbenzimide injs, see fig6G.

Case pg330, fig12, VTA90, table2. Soma notes not specified.. Terminal notes TB or bisbenzimide injs, see fig6E.

Case pg326, fig7, VTA61, table2. Soma notes not specified.. Terminal notes TB & bisbenzimide injs centred in different parts of ACB & dorsally adjacent parts of the striatum (see fig 6, VTA61).

Case pg330-333, fig13, VTA129, table2. Soma notes not specified.. Terminal notes TB & bizbenzimide injs, see fig6F, spread into PIR & other parts of cortex none of which receive input from VTA.

Case pg329, fig10, VTA92, table2. Soma notes not specified.. Terminal notes TB inj into supragenual field (Lindvall et al 78, BR142:1), see fig6C.

Case pg329-30, fig11, VTA91, table2. Soma notes not specified.. Terminal notes TB or bisbenzimide injs into pregenual field (Lindvall et al 78, BR142:1), see fig6D.

Case pg328-9, fig9, VTA70, table2. Soma notes not specified.. Terminal notes TB & bisbenzimide injs, only injections into medial 1/2 of nucleus labelled VTA region, (eg see fig6B).

Case pg333-4, fig15, VTA73, table2. Soma notes not specified.. Terminal notes TB & bizbenzimide injs, see fig6G.

Case pg334-5, fig17, VTA71, table2. Soma notes not specified.. Terminal notes TB & bizbenzimide injs, see fig6H.

Case pg326, fig7, VTA61, table2. Soma notes not specified.. Terminal notes TB & bisbenzimide injs centred in different parts of ACB & dorsally adjacent parts of the striatum (see fig 6, VTA61).

Case pg330-333, fig13, VTA129, table2. Soma notes not specified.. Terminal notes TB & bizbenzimide injs, see fig6F, spread into PIR & other parts of cortex none of which receive input from VTA.

Case pg329-30, fig11, VTA91, table2. Soma notes not specified.. Terminal notes TB or bisbenzimide injs into pregenual field (Lindvall et al 78, BR142:1), see fig6D.

Case pg326, fig7, VTA61, table2. Soma notes not specified.. Terminal notes TB & bisbenzimide injs centred in different parts of ACB & dorsally adjacent parts of the striatum (see fig 6, VTA61).

Case pg334-5, fig17, VTA71, table2. Soma notes not specified.. Terminal notes TB & bizbenzimide injs, see fig6H.

Case pg330, fig12, VTA90, table2. Soma notes not specified.. Terminal notes TB or bisbenzimide injs, see fig6E.

Case pg333, fig14. Soma notes By far largest projection found in lateral part of supramammillary region --Fig14: Most label bilaterally in SUMl, some in SUMm: moderate, Table2: 66% of all labled cellsare found in SUMl- partially crossed connx. Terminal notes In each of 3 animals, 2 large injs of true blue placed in dorsal (septal) part of hippocampal formation. In each animal injections labeled CA1 & CA3 & both blades of dentate gyrus; did not extend into thalamus but spread into ISO (ruled out by cntrl injs).

Case pg330-3, fig13, table2. Soma notes Over 2/3 of labeled cells in expts involving ENT found in MBO. Vast majojrity of these, (all non dopaminergic) located in lateral part of supramammillary region (ips). --Table2: 59% of all cells labeled found in SUMl-. Terminal notes TB & bizbenzimide injs, see fig6F, spread into PIR & other parts of cortex none of which receive input from VTA.

Case fig6C,10. Soma notes --Not mentioned in text, Fig10AB: moderate label shown in SUMm & SUMl, Table2: 38% of all labeled cells are found in SUMl-. Terminal notes In 2 experiments an injection of True blue centred in supragenual field (Fig6C). Results in each brain were similar. Use VTA92 as example.

Case pg329-30, fig6D,11. Soma notes ?supramammillary region ?projects to pregenual field; pathways predominantly uncrossed & non-dopaminergic. Most cells that give rise to these projections found in VTA & supramammillary region. --Fig11: moderate; Table2: 37% of all labeled cells in SUMm-. Terminal notes In 10 expts, pregenual field injecte with either true blue (9) or bisbenzimide (1); in several brains 2 large injection of true blue were made, to label maximally terminal field. Results of expt VTA91 representative of this group..

Case pg328-9, fig9, VTA70, table2. Soma notes major input (greater than HPF/PL). Terminal notes TB & bisbenzimide injs, only injections into medial 1/2 of nucleus labelled VTA region, (eg see fig6B).

Case pg333-4, fig15, VTA73, table2. Soma notes not specified.. Terminal notes TB & bizbenzimide injs, see fig6G.

Case pg330, fig12, VTA90, table2. Soma notes not specified.. Terminal notes TB or bisbenzimide injs, see fig6E.

Case pg333, fig14. Soma notes By far largest projection found in lateral part of supramammillary region --Fig14: Most label bilaterally in SUMl, some in SUMm: sparse, Table2: 2% of all labeled cells- partially crossed connx. Terminal notes In each of 3 animals, 2 large injs of true blue placed in dorsal (septal) part of hippocampal formation. In each animal injections labeled CA1 & CA3 & both blades of dentate gyrus; did not extend into thalamus but spread into ISO (ruled out by cntrl injs).

Case pg330-3, fig13, table2. Soma notes --Fig13: only few cells in SUMm, Table2: 2% of all cells labeled found in SUMm-. Terminal notes lateral part of entorhinal area injected in 5 animals, true blue(4), bisbenzimide(1). In each expt inj spread dorsally into overlying regions of neocortex & in some expts into piriform cortex. None spread to other parts of HPF.

Case fig6C,10. Soma notes --Not mentioned in text, Fig10AB: moderate label shown in SUMm & SUMl, Table2: 2% of all labeled cells are found in SUMm-. Terminal notes In 2 experiments an injection of True blue centred in supragenual field (Fig6C). Results in each brain were similar. Use VTA92 as example.

Case pg329-30, fig6D,11. Soma notes ?supramammillary region ?projects to pregenual field; pathways predominantly uncrossed & non-dopaminergic. Most cells that give rise to these projections found in VTA & supramammillary region. --Fig11: moderate; Table2: 10% of all labeled cells in SUMm-. Terminal notes In 10 expts, pregenual field injecte with either true blue (9) or bisbenzimide (1); in several brains 2 large injection of true blue were made, to label maximally terminal field. Results of expt VTA91 representative of this group..

Case pg328-9, fig9, VTA70, table2. Soma notes not specified.. Terminal notes TB & bisbenzimide injs, only injections into medial 1/2 of nucleus labelled VTA region, (eg see fig6B).

Case pg330, fig12, VTA90, table2. Soma notes not specified.. Terminal notes TB or bisbenzimide injs, see fig6E.

Case pg326, fig7, VTA61, table2. Soma notes not specified.. Terminal notes TB & bisbenzimide injs centred in different parts of ACB & dorsally adjacent parts of the striatum (see fig 6, VTA61).

Case pg333. Soma notes By far largest projection found in SUM & tuberomammillary nucleus --Table2: 12% of all labeled cells found in TM.- partially crossed connx. Terminal notes In each of 3 animals, 2 large injs of true blue placed in dorsal (septal) part of hippocampal formation. In each animal injections labeled CA1 & CA3 & both blades of dentate gyrus; did not extend into thalamus but spread into ISO (ruled out by cntrl injs).

Case pg330-3, table2. Soma notes In addition, some cells were found on both sides of the brain ?in tuberomammillary nucleus --Table2: 10% of all labeled cells are found in TM: moderate-. Terminal notes lateral part of entorhinal area injected in 5 animals, true blue(4), bisbenzimide(1). In each expt inj spread dorsally into overlying regions of neocortex & in some expts into piriform cortex. None spread to other parts of HPF.

Case fig6C,10. Soma notes --Not mentioned in text; Fig10: few cells in TM shown; Table2: 8% of all labeled cells are found in TM: sp/mod-. Terminal notes In 2 experiments an injection of True blue centred in supragenual field (Fig6C). Results in each brain were similar. Use VTA92 as example.

Case pg329-30, fig6D,11. Soma notes ?tuberomammillary region ?projects to pregenual field; pathways predominantly uncrossed & non-dopaminergic. --Fig11: sparse??? nucleus small; Table2: 4% of all labeled cells are found in TM-. Terminal notes In 10 expts, pregenual field injecte with either true blue (9) or bisbenzimide (1); in several brains 2 large injection of true blue were made, to label maximally terminal field. Results of expt VTA91 representative of this group..

Case pg328-9, fig9, VTA70, table2. Soma notes not specified.. Terminal notes TB & bisbenzimide injs, only injections into medial 1/2 of nucleus labelled VTA region, (eg see fig6B).

Case pg333-4, fig15, VTA73, table2. Soma notes not specified.. Terminal notes TB & bizbenzimide injs, see fig6G.

Case pg326, fig7, VTA61, table2. Soma notes not specified.. Terminal notes TB & bisbenzimide injs centred in different parts of ACB & dorsally adjacent parts of the striatum (see fig 6, VTA61).